Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-001393
Filing Date
2020-01-17
Accepted
2020-01-17 18:07:02
Documents
2
Period of Report
2020-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3803
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3836
  Complete submission text file 0000899243-20-001393.txt   9324
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Issuer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 733 CONCORD AVENUE C/O WAVE LIFE SCIENCES USA, INC. CAMBRIDGE MA 02138
Business Address
Gaiero David G (Reporting) CIK: 0001799784 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37627 | Film No.: 20534601